Niagen Bioscience, Inc.

NAGESEC EDGAR

Medicinal Chemicals & Botanical Products(DE)CIK: 1386570

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues	$99.6M	$83.6M	$72.0M	$67.4M	$59.3M
Cost of Revenue	$38.0M	$32.8M	$29.3M	$26.0M	$24.0M
Gross Profit	$61.6M	$50.8M	$42.8M	$41.5M	$35.3M
Research and Development Expense	$6.0M	$5.0M	$4.8M	$3.8M	$3.4M
Operating Expenses	$53.9M	$56.4M	$61.4M	$68.6M	$55.1M
Operating Income (Loss)	$7.7M	-$5.6M	-$18.6M	-$27.1M	-$19.9M
Interest Expense	—	—	—	—	$71.0K

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$68.3M	$55.0M	$54.1M	$57.8M	$38.4M
Assets, Current	$64.1M	$49.5M	$46.6M	$48.9M	$32.2M
Cash and Cash Equivalents, at Carrying Value	—	$44.5M	$27.2M	$20.3M	$16.7M
Accounts Receivable, after Allowance for Credit Loss, Current	$7.8M	—	—	$5.2M	$2.7M
Inventory, Net	—	$14.5M	$14.7M	$13.6M	$11.7M
Liabilities	$22.2M	$26.5M	$25.4M	$26.1M	$21.9M
Liabilities, Current	$17.9M	$20.6M	$17.9M	$17.6M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$12.1M	$7.1M	-$15.1M	-$24.2M	-$10.6M
Net Cash Provided by (Used in) Investing Activities	-$143.0K	-$143.0K	-$334.0K	-$409.0K	-$165.0K
Net Cash Provided by (Used in) Financing Activities	$5.4M	-$90.0K	$7.7M	$36.1M	$8.7M
Payments to Acquire Property, Plant, and Equipment	—	—	—	—	—
Payments for Repurchase of Common Stock	$0.00	—	—	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)